- Home
- NERV vs CARV Comparison
NERV vs CARV Comparison
Compare NERV & CARV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- CARV
- Stock Information
- Founded
- NERV 2007
- CARV 1948
- Country
- NERV United States
- CARV United States
- Employees
- NERV N/A
- CARV N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- CARV Savings Institutions
- Sector
- NERV Health Care
- CARV Finance
- Exchange
- NERV Nasdaq
- CARV Nasdaq
- Market Cap
- NERV 14.6M
- CARV 14.5M
- IPO Year
- NERV 2014
- CARV 1994
- Fundamental
- Price
- NERV $4.78
- CARV $2.77
- Analyst Decision
- NERV Hold
- CARV
- Analyst Count
- NERV 1
- CARV 0
- Target Price
- NERV $5.00
- CARV N/A
- AVG Volume (30 Days)
- NERV 9.3M
- CARV 20.4K
- Earning Date
- NERV 11-05-2025
- CARV 11-13-2025
- Dividend Yield
- NERV N/A
- CARV N/A
- EPS Growth
- NERV N/A
- CARV N/A
- EPS
- NERV 1.48
- CARV N/A
- Revenue
- NERV N/A
- CARV $22,032,000.00
- Revenue This Year
- NERV N/A
- CARV N/A
- Revenue Next Year
- NERV N/A
- CARV N/A
- P/E Ratio
- NERV $3.06
- CARV N/A
- Revenue Growth
- NERV N/A
- CARV N/A
- 52 Week Low
- NERV $1.15
- CARV $1.30
- 52 Week High
- NERV $12.46
- CARV $3.85
- Technical
- Relative Strength Index (RSI)
- NERV 63.84
- CARV 56.93
- Support Level
- NERV $4.27
- CARV $2.66
- Resistance Level
- NERV $12.46
- CARV $2.89
- Average True Range (ATR)
- NERV 0.86
- CARV 0.15
- MACD
- NERV 0.16
- CARV -0.02
- Stochastic Oscillator
- NERV 24.84
- CARV 42.50
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About CARV Carver Bancorp Inc.
Carver Bancorp Inc is a holding company and conducts its business as a unitary saving and loan holding firm and the business of the company consists of the operation of its subsidiary. The bank offers a wide range of financial solutions to meet customers' banking. It offers other consumer and commercial banking products and services, such as debit cards, online banking, online bill pay, and telephone banking. The company provides deposit products, such as demand, savings, and time deposits for consumers, businesses, and governmental and quasi-governmental agencies in its market area within New York City.